NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 194 filers reported holding NOVAVAX INC in Q2 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $474,000 | -54.3% | 860,000 | +502.6% | 0.23% | +322.2% |
| Q2 2016 | $1,038,000 | -72.1% | 142,726 | -72.9% | 0.05% | -64.9% |
| Q3 2015 | $3,726,000 | +92.8% | 527,040 | +26.0% | 0.15% | +85.5% |
| Q2 2014 | $1,933,000 | +69.7% | 418,378 | +66.4% | 0.08% | +29.7% |
| Q1 2014 | $1,139,000 | +639.6% | 251,500 | +738.3% | 0.06% | +540.0% |
| Q4 2013 | $154,000 | -94.4% | 30,000 | -96.6% | 0.01% | -94.4% |
| Q3 2013 | $2,765,000 | – | 875,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |